Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
101 studies found for:    Migraine AND 5-ht1 receptor
Show Display Options
Rank Status Study
1 Completed Determine Central 5-HT1B Receptor Occupancy of ZOMIG® Rapimelt (Zolmitriptan) in Healthy Male Volunteers
Condition: Migraine
Interventions: Drug: Rapimelt;   Drug: [11C]AZ10419369
2 Recruiting Investigation of Serotonin Receptor Binding in the Migraine Brain Using Positron Emission Tomography
Condition: Migraine Without Aura
Intervention: Other: PET scan with two different 5-HT receptor ligands
3 Unknown  Treximet in Acute Migraine Headache: Assessing Cognitive Function
Conditions: Migraine Headache;   Cognitive Impairment
Interventions: Drug: Treximet;   Drug: Migraine rescue medication of choice
4 Completed Comparison of Treximet & Imitrex as They Affect the Levels of Inflammatory Markers When the Patient is Actively Having a Migraine Headache
Condition: Migraine
Intervention: Drug: sumatriptan and Treximet
5 Unknown  Efficacy of Sumatriptan With Naprosyn in Migraine With Aura
Condition: Migraine With Aura
Interventions: Drug: sumatriptan with naprosyn;   Drug: placebo
6 Completed Efficacy and Safety of BGG492 in the Treatment of Migraine
Condition: Migraine
Interventions: Drug: BGG492;   Drug: Sumatriptan;   Drug: Placebo
7 Completed Migraine Treatment Satisfaction With Treximet Versus Concomitant 2 Aleve and Imitrex
Condition: Migraine
Interventions: Drug: Treximet;   Drug: Imitrex and two Aleve
8 Completed A Study on the Usability of the Needle-Free Intraject® System in Adult Patients During Acute Migraine Attack
Condition: Migraine Headache
Intervention: Device: Intraject Sumatriptan
9 Completed
Has Results
Evaluation of Treatment Satisfaction and Preference for Sumavel DosePro in the Treatment of Migraine
Condition: Migraine
Interventions: Device: Sumavel DosePro;   Drug: Sumatriptan
10 Completed
Has Results
Study of Telcagepant (MK-0974) in Participants With Moderate to Severe Acute Migraine With or Without Aura (MK-0974-011)
Condition: Migraine
Interventions: Drug: Telcagepant potassium 150 mg;   Drug: Telcagepant potassium 300 mg;   Drug: Zolmitriptan 5 mg;   Drug: Placebo to telcagepant 150 mg;   Drug: Placebo to tecagepant 300 mg;   Drug: Placebo to zolmitriptan 5 mg;   Drug: Rescue medication
11 Completed A Study to Assess an Auto-injector Being Used to Treat a Migraine Attack
Condition: Migraine
Intervention: Drug: "Investigational"Auto-injector (sumatriptan succinate)
12 Completed Dose Ranging Study of a Drug for the Treatment of Acute Migraine
Condition: Migraine - Acute
Interventions: Drug: Placebo matching BMS-927711;   Drug: BMS-927711;   Drug: Sumatriptan
13 Completed
Has Results
"Completeness of Response" Following Treatment With Treximet™ for Migraine
Condition: Migraine
Intervention: Drug: sumatriptan succinate 85 mg/naproxen sodium 500 mg (Treximet)
14 Completed
Has Results
Efficacy and Safety of 20 mg Sumatriptan Powder Delivered Intranasally With the Bi-directional Device Compared With 100 mg Sumatriptan Tablets in Adults With Acute Migraine With or Without Aura
Conditions: Migraine;   Headaches
Interventions: Drug: 100 mg Sumatriptan Tablet and OPTINOSE Placebo delivered nasally;   Drug: OPTINOSE SUMATRIPTAN delivered nasally and placebo tablet
15 Completed Phase I, Open Label, Single-Dose, Four Way Crossover Study to Compare the PK of NP101 With Oral Imitrex® (50mg) in Migraine Subjects During an Acute Migraine Attack and During a Non-Migraine Period
Condition: Migraine Disorders
Interventions: Drug: Sumatriptan succinate;   Drug: NP101 Study Patch
16 Completed Zolmitriptan Nasal Spray Versus Eletriptan in the Acute Treatment of Migraine
Conditions: Acute Migraine;   Migraine Headache;   Headache Disorders
Interventions: Drug: Zolmitriptan 5 mg Nasal Spray;   Drug: Eletriptan 40 mg tablet
17 Completed
Has Results
Study of NXN 188 for the Treatment of Migraine With Aura
Condition: Migraine With Aura
Interventions: Drug: NXN-188;   Drug: placebo;   Drug: sumatriptan succinate
18 Completed
Has Results
Study to Evaluate the Efficacy and Safety of Oral Sumatriptan for the Acute Treatment of Migraine in Children and Adolescents
Condition: Migraine Disorders
Interventions: Drug: Sumatriptan 25 mg;   Drug: Sumatriptan 50 mg;   Drug: Placebo
19 Completed
Has Results
Ictal and Interictal Inflammatory Markers in Migraine
Condition: Migraine
Interventions: Drug: Treximet;   Drug: Placebo
20 Completed
Has Results
Treximet Early Intervention Adolescent Migraine
Condition: Migraine
Interventions: Drug: Treximet;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.